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ABSTRACT Many bioactive peptides require amidation of their carboxy terminus to exhibit full biological activity. Peptidylglycine
a-hydroxylating monooxygenase (PHM; EC 1.14.17.3), the enzyme that catalyzes the ﬁrst of the two steps of this reaction, is
composed of two domains, each of which binds one copper atom (CuH and CuM). The CuM site includes Met314 and two His
residues as ligands.Mutation ofMet314 to Ile inactivatesPHM, but has only aminimal effect on theEXAFSspectrumof the oxidized
enzyme, implying that it contributes only marginally to stabilization of the CuM site. To characterize the role of Met314 as a CuM
ligand, we determined the structure of the Met314Ile-PHMmutant. Since the mutant protein failed to crystallize in the conditions of
the original wild-type protein, this structure determination required ﬁnding a new crystal form. TheMet314Ile-PHMmutant structure
conﬁrms that the mutation does not abolish CuM binding to the enzyme, but causes other structural perturbations that affect the
overall stability of theenzymeand the integrity of theCuHsite. Toeliminate possible effects of crystal contacts,we redetermined the
structure of wt-PHM in theMet314Ile-PHM crystal form and showed that it does not differ from the structure of wild-type (wt)-PHM in
the original crystals. Met314Ile-PHM was also shown to be less stable than wt-PHM by differential scanning calorimetry. Both
structural and calorimetric studies point to a structural role for the CuM site, in addition to its established catalytic role.
INTRODUCTION
Many bioactive peptides require a carboxy-terminal a-amide
(CONH2) for activity (for reviews, see (1–3)). Peptide amida-
tion is catalyzed by a single, bifunctional enzyme named
PAM (EC 1.14.17.3), short for peptidylglycine a-amidating
monooxygenase. PAM is composed of two enzymatic
domains: peptidylglycine a-hydroxylating monooxygenase
(PHM; EC 1.14.17.3) and peptidyl-a-hydroxyglycine ami-
dating lyase (PAL; EC 4.3.2), that act sequentially on a
glycine-extended propeptide as shown in Fig. 1 (4).
The reaction catalyzed by PHM has been extensively
studied using a variety of techniques, including x-ray crys-
tallography (5,6), extended x-ray absorption ﬁne spectroscopy
(EXAFS) (7,8), electron paramagnetic resonance (7,9),
ﬂuorescence (10), kinetic analysis (11), and mutagenesis
(7). PHM is a dicopper monooxygenase that catalyzes the
stereospeciﬁc a-hydroxylation of the peptidylglycine sub-
strate by molecular oxygen (O2). The two copper atoms,
CuH (also named CuA) and CuM (also named CuB), are
essential for activity (12) and cycle between Cu(I) and Cu(II)
during catalysis (9). Reduction of the copper ions is carried
out independently by two molecules of ascorbate, which are
oxidized to semidehydroascorbate. Each copper contributes
one electron to the overall reaction, and the required electron
transfer between the copper sites only occurs in the presence
of both substrate and dioxygen (9).
X-ray diffraction studies of PHMcc, the catalytic core of
the PHM domain of rat PAM-1 (residues 42–356, hereafter
referred to as PHM for simplicity) (13), have shown that the
two copper atoms are 11 A˚ apart, separated by a solvent-
ﬁlled cleft (5). CuH coordination is unusual and can be de-
scribed as square pyramidal with three histidines (His107,
His108, His172) and two unoccupied positions (‘‘T-shape’’
coordination). By contrast, CuM is coordinated by two
histidines (His242, H244), a methionine (Met314) and a water
molecule (or OH) in a slightly distorted tetrahedral geom-
etry. Comparison of the reduced and oxidized structures
shows only minor changes (Ca root mean-square deviation
(RMSD)  0.2 A˚), even in the coordination of the copper
ions (slight motion of His108 only).
However, recent EXAFS experimental data (14) were
interpreted as indicating a signiﬁcant lengthening of the
Met314Sg to CuM distance from 2.25 A˚ in the reduced form
to 2.8 A˚ in the oxidized form. In the crystallographic struc-
tures (5,6,15), the corresponding distances are either 2.27A˚
(Protein Data Bank (PDB)-1sdw) or 2.45 A˚ (PDB-3phm) in
the reduced form and either 2.38A˚ (PDB-1opm) or 2.42A˚
(PDB-1phm) in the oxidized form.
Mutation of Met314 to Ile (Met314Ile) inactivates PHM (7),
but this substitution results in minimal changes in the EXAFS
spectrum of the oxidized enzyme (14), implying that methi-
onine coordination contributes minimally to the stabiliza-
tion of Cu(II) at the CuM site. Upon reduction, EXAFS and
absorption edge data show signiﬁcant differences between
Met314Ile-PHM and wild-type (wt)-PHM (14). Previous
studies also showed that substitution of Met314 with His or
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Cys (that could potentially still bind CuM) did not restore
catalytic activity (13).
To explore further the role of the Met314 ligand, we de-
termined the structures of the Met314Ile mutant in both
oxidized (ox-Met314Ile-PHM) and reduced (red-Met314Ile-
PHM) states. Since the Met314Ile-PHM protein does not crys-
tallize under the same conditions as wt-PHM (PDB-1opm,
1phm, 3phm, 1sdw), we redetermined the oxidized and re-
duced structures of wt-PHM in the new crystal form (ox-
wt-PHM and red-wt-PHM, respectively), to eliminate the
possibility of artifacts due to crystal contacts.
To evaluate the effect of the Met314Ile mutation on the sta-
bility of the enzyme,wemeasured the excess heat capacity (Cp,
ex) of wt-PHM and of Met
314Ile-PHM as a function of tem-
perature using differential scanning calorimetry (DSC). Both
structural and calorimetric studies point to a structural role for
the CuM site, in addition to its established catalytic role.
MATERIAL AND METHODS
Protein expression and puriﬁcation
Stably transfected Chinese hamster ovary (CHO) cell lines secreting PHMcc
were constructed using the pCIS vector system as described before (13).
Details of cell culture and protein puriﬁcation, copper reconstitution and
activity measurements were provided elsewhere (5,7). Stably transfected cell
lines carrying the Met314Ile mutation were constructed as reported pre-
viously (7). The Met314Ile-PHM puriﬁcation and copper reconstitution were
described before (14,16).
Protein crystallization and diffraction
data collection
Puriﬁed Met314Ile-PHM and wt-PHM were concentrated to 15 mg/ml in
50 mM Na-Hepes (pH 6.8) and 50 mM NaCl. Since Met314Ile-PHM did not
crystallize in the conditions published for wt-PHM (5) (525 mM CuSO4,
3.08 mM NaN3, 100 mM dimethylarsinic acid pH 5.5, at 298 K), we found
new crystallization conditions with incomplete factorial screening using
hanging-drop vapor-diffusion at 293K. Met314Ile crystals appeared after
a week in drops composed of 2 ml of protein and 2 ml of a reservoir solution
containing 27% (w/v) PEG-4000, 600 mM MgCl2, 100 mM Tris pH 8.5.
Crystals were frozen at 93 K in the reservoir solution with added 5 mM
CuSO4 and 30% glycerol as cryoprotectant. Diffraction data were collected
on single frozen crystals, either at a home source (Rigaku RU-200 rotating
anode generator and R-AXIS IV image plate detector) or at a beam line (X25
or X26C) of the National Synchrotron Light Source at Brookhaven National
Laboratory (Upton, NY) (Table 1). Data reduction was carried out using the
programs MOSFLM and SCALA from the CCP4 suite (17).
The Met314Ile crystals belong to the orthorhombic space group P212121
with unit cell dimensions a¼ 59.5 A˚, b ¼ 66.5 A˚, c ¼ 70.0 A˚, a ¼ b¼ g ¼
90 and one Met314Ile-PHM molecule per asymmetric unit. The Met314Ile
crystal form differs from that of the original wt-PHM crystals (5) (a ¼
69.4 A˚, b¼ 68.8 A˚, c¼ 81.0 A˚, a¼ b¼ g ¼ 90, space group P212121). To
compare Met314Ile-PHM and wt-PHM in the same crystal form, crystals of
wt-PHM were grown in the new crystallization conditions using micro-
seeding techniques. These crystals also belong to the orthorhombic space
group P212121 with unit cell dimensions highly similar to those of the
Met314Ile crystals (a ¼ 58.5 A˚, b ¼ 65.7 A˚, c ¼ 69.9 A˚, a ¼ b ¼ g ¼ 90).
Data collection statistics are given in Table 1.
Structure reﬁnement
The same overall procedure was used for all four structures (ox-Met314Ile-
PHM, red-Met314Ile-PHM, ox-wt-PHM, red-wt-PHM): the published coor-
dinates of wt-PHM (PDB-1opm for the oxidized state and PDB-3phm for the
reduced state) were positioned in the unit cell with the program AMoRe (18)
and used as the starting model for alternate cycles of model building and
reﬁnementusing theprogramsO(19)andREFMAC5.0 (20).Fivepercentof the
reﬂections were set aside from the beginning of the reﬁnement to calculate the
Rfree values. Solvent molecules were added automatically using ARP/WARP
(21) and visually inspected with the program O (19). The geometrical integrity
of the structures was checked throughout reﬁnement using the program
MolProbity (22). The crystallographic statistics are summarized in Table 1.
Differential scanning calorimetry
Measurements for wild-type PHM and the Met314Ile-PHM mutant were
carried out on a VP-DSC microcalorimeter (MicroCal, Northampton, MA)
at the Biocalorimetry Center of the Johns Hopkins University (Baltimore,
MD). The scanning rate was 60/h. Proteins (wt and Met314Ile) were con-
centrated to 0.1 mg/ml in buffers containing 50 mM MES pH 6.8, 50 mM
NaCl, and 5 mM CuSO4. Protein and buffer solutions were properly
degassed and carefully loaded into the cells to avoid bubble formation.
RESULTS AND DISCUSSION
Overall structure of ox-Met314Ile-PHM
Structural alignment (Ca RMSD ¼ 0.947 A˚) between ox-
Met314Ile-PHM and the published structure of oxidized
wt-PHM (PDB-1opm) shows differences in the N-terminus
and in the 177–182 region (Fig. 2), but the most relevant
main-chain changes are located close to the CuM site: the
mutated residue Ile314 is displaced away from CuM, causing
the ﬂanking loop (299-313) to become highly disordered
(dashed lines in Fig. 2) and the loop 212-218 to move away
from CuM (Ca of Gly
217 displaced by as much as 5 A˚). The
FIGURE 1 Overall mechanism of PAM, show-
ing the sequential action of its two catalytic
domains, PHM and PAL, on a glycine-extended
propeptide.
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effect of the mutation on the stability of the 299-313 loop
does not propagate to residues past Met314, because Cis315 is
constrained by a disulﬁde bridge to Cis293 (see Fig. 3).
It may be argued that these changes are the result of crystal
packing differences between PDB-1opm and ox-Met314Ile-
PHM because different crystal forms were used to determine
these structures. In PDB-1opm, wt-PHM crystallizes with an
adventitious crystal contact involving His305 from one mole-
cule, His235 from a symmetry-related molecule, and three
components from the crystallization buffer: a Ni21 ion, an
azide molecule and a glycerol molecule (Fig. 2, inset).
Importantly, His305 is located in the middle of the 299-313
loop that is disordered in ox-Met314Ile-PHM, which does not
require Ni21 for crystallization, has different unit cell dimen-
sions and uses different crystal contacts.
To ﬁnd out unambiguously whether the destabilization of
the loop is caused by the loss of the crystal contact involving
His305 or by the Met314Ile mutation itself, we redetermined
the oxidized and reduced structures of wt-PHM in the
Met314Ile-PHM crystal form (see Methods and Table 1). We
refer to the new oxidized and reduced structures as ox-wt-
PHM and red-wt-PHM, respectively.
Redetermination of the structure of
oxidized wt-PHM
The oxidized structures of wt-PHM in the two crystal forms
(ox-wt-PHM and PDB-1opm, Fig. 4) have a Ca RMSD of
0.721 A˚, the difference being mostly located in the regions
that were shifted in the ox-Met314Ile-PHM structure (Fig. 2).
The shifts in N-terminus and in the loop 174-184 are similar
in ox-wt-PHM and ox-Met314Ile-PHM (Figs. 2 and 4) and
can thus be attributed to the change in crystal form. The
change in the loops 212-218 and 305-313 is less pronounced
in ox-wt-PHM than in ox-Met314Ile-PHM, and therefore
results mostly from the mutation.
Most importantly, the 299-313 loop of ox-wt-PHM is well
ordered ( ÆBæ¼ 34.4 A˚2 for ox-wt-PHM and 38.3 A˚2 for the
PDB-1opm), showing that the cause of the destabilization
of the 299-313 loop in ox-Met314Ile-PHM is the mutation
Met314Ile ﬂanking the loop, and not the change in crystal
contacts. It is interesting to note that the structure of wt-PHM
at pH 8.5 (ox-wt-PHM) is very similar to that at the phys-
iological pH 5.5 (PDB-1opm), with essentially identical
copper binding sites. This ﬁnding validates the results of ex-
TABLE 1 Statistics of crystallographic analysis and reﬁnement
Ox-wt-PHM Red-wt-PHM Ox-Met314Ile-PHM Red-Met314Ile-PHM
Data collection
Wavelength (A˚) 1.54 1.10 1.10 1.10
X-ray source Home X25 X25 X26C
Space group P212121 P212121 P212121 P212121
No. of observed reﬂections 65470 85900 61959 49563
No. of unique reﬂections 14082 19172 28704 11215
Redundancy 4.7 (4.7) 4.5 (4.7) 2.5 (1.4) 4.5 (4.6)
Completeness (%) 92.9 (90.4) 99.5 (99.9) 87.6 (48.8) 99.5 (99.7)
Signal ÆðI=sðIÞÞæ 18.8 (2.18) 9.2 (3.0) 8.8 (1.8) 4.3 (1.7)
Rsym (%) 5.8 (44.4) 5.4(23.9) 4.1 (37.5) 6.5 (44.5)
Resolution (A˚) 2.2 2.0 1.7 2.4
Model composition (nonhydrogen atoms)
No. of amino acids 45–355 47–355 47–355 50–355
No. of active site Cu 2 2 2 0
No. of water molecules 154 83 130 47
No. of total atoms 2581 2505 2469 2319
Reﬁnement
Rcryst (%) 18.6 19.0 19.6 18.8
Rfree (%) 25.0 26.1 23.3 27.1
Stereochemistry
Root mean-square for bond length (A˚) 0.042 0.024 0.026 0.033
Root mean-square for bond angles (deg) 3.0 2.2 2.3 2.7
ÆBæ(A˚2) 33.1 33.4 41.7 51.3
Numbers in parenthesis correspond to the last resolution shell. X-ray sources are either a home source (Rigaku RU-200 rotating anode generators and
R-AXIS IV image plate detectors) or a beam line (X25 or X26C) of the National Synchrotron Light Source, Brookhaven National Laboratory (red, reduced;
ox, oxidized).
Rsym ¼ +hkl+ijIðhklÞ  ÆIðhklÞæj=+hkl+ijIðhklÞj:
Rcryst ¼ +hklkFobsðhklÞj  FcalcðhklÞk=+hkljFobsðhklÞj:
Rfree was calculated as in Bru¨nger (32), using 5% of the data for the test set.
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periments performed at a nonphysiological pH (e.g., EXAFS
performed at pH 7.5 (7,8)).
Effects of the Met314Ile mutation on the active site
Surprisingly, removal of the Met314 ligand to CuM does not
abolish the binding of CuM, as shown by the spherical
anomalous diffraction difference Fourier density found at the
position of CuM in ox-Met314Ile-PHM (Fig. 5 A). The CuM
site in ox-Met314Ile-PHM (Fig. 5 A) accommodates the
mutation by replacing Met314Sg with a water molecule, and
by shifting the positions of the other coordinating residues
(His242, His244, and a water molecule), to form a distorted
tetrahedron. Some disorder can be observed at the CuM site
as a result of the mutation: the B-factors are higher than
average for CuM and for the Ne of His
242 and His244 (65 A˚2,
55 A˚2, and 60 A˚2; ÆB (protein)æ ¼ 37.8 A˚2) and at lower
contour levels, the anomalous diffraction difference Fourier
map around CuM becomes elongated in the direction per-
pendicular to the line joining the Ne of His
242 and His244
(data not shown).
Unexpectedly, the CuH site appears to be much more
affected by the Met314Ile mutation than the CuM site, even
though the two copper ions are 11 A˚ apart, without any sig-
niﬁcant structural change in the protein regions connect-
ing them (Fig. 4). In particular, His107 and CuH are highly
disordered in the ox-Met314Ile-PHM structure, and reﬁned
to occupancies of 30% with B-factors 39 A˚2 and 54 A˚2,
respectively. The anomalous signal of CuH is weaker than
that of CuM; the anomalous diffraction difference Fourier
map around CuH differs signiﬁcantly from a spherical shape
(Fig. 5 A), indicating disorder and/or partial occupancy. Only
two histidines (His108 and His172) coordinate CuH linearly,
whereas His107 is disordered, as conﬁrmed by the Fo-Fc omit
map (contoured at 2 s; Fig. 5 B) generated from a model that
omitted both copper atoms and their coordinating residues.
Fig. 5, C and D, show that both copper sites of the ox-wt-
PHM structure (same crystal form as ox-Met314Ile-PHM) are
essentially identical to those of PDB-1opm, proving that the
changes observed in the ox-Met314Ile-PHM structure at CuH
and CuM are caused by the Met314Ile mutation, and not by
the change in crystal contacts. The electron density map in
FIGURE 3 Region next to the Met314Ile mutation (residues 315–319) and
the neighboring chain (residues 293–289) in the ox-Met314Ile structure,
showing the disulﬁde bridge between C315 and C293 and the electron
density map, contoured at 1 s. This ﬁgure was prepared with PyMOL (34).
FIGURE 2 Superposition of the structures of PDB-
1opm (magenta) and ox-Met314Ile-PHM (red). Labeled
residues delimit regions where the main chains PDB-1opm
and ox-Met314Ile-PHM differ signiﬁcantly. The dashed
region represents the loop 299-313 that is too disordered to
be traced in Met314Ile-PHM. The insert depicts the
adventitious crystal contact in PDB-1opm that involves
His305, a Ni21 ion, an azide molecule, a glycerol molecule
(from the crystallization buffer), and His235 (from a sym-
metry-related molecule). Ribbon diagrams were generated
with MolScript (33).
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Fig. 3 showing a well ordered region of the Met314Ile-PHM
structure can serve as evidence of the overall quality of the
data, giving credence to the structural changes shown in Fig.
5, A and B. During this study, several data sets were col-
lected, both at a home source and at the synchrotron, and all
of them systematically revealed that the mutation at CuM
propagates to CuH (data not shown).
EXAFS studies (14) have also detected mobility of a His
ligand to CuH, resulting in a linear coordination of this
copper in the reduced form of the protein. Although the
mobile histidine was assumed to be His172 (8,14), the dis-
order observed in the crystal structure for His107 assigns this
role to His107. Other published reports have also suggested
a connection between the properties of the two copper sites.
For example, coupling of the movement of Met314 to the
occupancy of the CuH site has been observed by EXAFS
(23), and carbon monoxide (CO) binding studies (16) have
shown that binding of substrate near CuM favors binding of
CO to CuH. Together, these data highlight a structural role of
the CuM site that has far-reaching implications on the
integrity of the CuH site.
Differential scanning calorimetry
To evaluate the effect of the Met314Ile mutation on the over-
all stability of the PHM protein, we investigated the thermal
denaturation of wt-PHM and of Met314Ile-PHM using dif-
ferential scanning calorimetry. Both proteins denatured
irreversibly (Fig. 6), probably due to the loss of Cu upon
unfolding, but their behavior is signiﬁcantly different. The
denaturation is centered at a lower temperature for the mu-
tant than for the native (75.9C for wt-PHM and 73C for
Met314Ile-PHM), indicating that the loss of the CuM-S bond
has an important destabilizing effect on the structure of PHM.
Structural role of CuM site
The structural and calorimetric data indicate that the Met314Ile
mutation perturbs the stability of the enzyme, which in turn
affects the ability of copper to bind to the CuH site. This
suggests that the CuH site in wt-PHM is tailored to hold
copper in its unusual coordination, and is therefore sensitive
to the overall stability of the protein. By contrast, CuM forms
a stable complex with only the two histidines, as observed in
the structure of Met314Ile-PHM. This partial complex is able
to bind to the S atom of Met314 and use this bond to anchor
the loop containing residues 299–314 against the copper,
adding stability to the protein and preforming the CuH bind-
ing site. Interestingly, the Glu313Asp mutant shows altered
catalytic properties (data not shown), possibly because it also
destabilizes the 299-313 loop. The mechanistic importance
of the stabilizing Met314-CuM interaction has also been pre-
dicted by density functional calculations (24,25).
Thus, the CuM site plays a signiﬁcant structural role, in
addition to its established catalytic function (15). Copper ions
usually play catalytic roles in enzymes, although they have
been shown to be important structurally in some cases such as
the type 3 active site copper of human ceruloplasmin (26) and
hemocyanin (27). PHM therefore offers a rare example of
a copper site playing major structural and catalytic roles.
Structural effects of reduction
The structure of red-Met314Ile-PHM shows that upon reduc-
tion the mutant loses both CuH and CuM, as indicated by the
lack of anomalous signal (see Supplementary Material). In
addition, all active-site histidines become more mobile.
These effects appear to be caused by the mutation and not by
the crystal contacts, since red-wt-PHM retains both copper
FIGURE 4 Superposition of the structures of PDB-
1opm (magenta) and ox-wt-PHM (mustard). Labeled
residues delimit regions where the main chains PDB-
1opm and ox-wt-PHM differ signiﬁcantly. Ribbon dia-
grams were generated with MolScript (33).
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ions upon reduction (see Supplementary Material). The
reduced structures of red-wt-PHM and PDB-3phm differ
only in the conformations of the loops 174-184, 212-218,
and 299-313 (Ca RMSD ¼ 0.940 A˚) and no main-chain
conformational changes are observed in the protein region
connecting the two copper sites. As in ox-Met314Ile-PHM,
the 299-313 loop ﬂanking the mutation is highly disordered
in red-Met314Ile-PHM. This observation is further evidence
that reduction does not trigger major conformational changes
during the catalytic cycle: in two crystal forms, with different
crystal contacts, no major structural differences are observed
between the oxidized and the reduced forms.
SUMMARY AND CONCLUSIONS
The crystal structure of Met314Ile-PHM reveals that in addi-
tion to its established catalytic role, the CuM site of PHM
plays an essential role in the structural integrity of the en-
zyme. This effect is conﬁrmed by the lower thermal stability
of the mutant enzyme with respect to the wild-type, as mea-
sured by DSC. The structural role of CuM in PHM appears to
be twofold. First, CuM anchors the active conformation of
the 299-314 loop and, as shown by the DSC experiment, the
CuM-Met314 coordination stabilizes the protein. Second, the
stabilized structure has a preformed CuH site that allows
copper to bind with an unusual coordination. This arrange-
ment may be important for adjusting the electrochemical
potentials of reduced CuH and CuM to favor electron trans-
fer, as shown in the constrained coordination of blue copper
proteins (28). The effect of the coordination of the CuM site
on the ordering of the CuH site is remarkable, because CuH
and CuM are located 11 A˚ apart, on opposite faces of a
solvent-ﬁlled cleft. Neither the Met314Ile mutation nor
reduction causes major conformational change in the region
of the protein connecting the two copper sites. These results
also clarify previous results of EXAFS experiments that
detected motion of a histidine ligand to CuH upon reduction
of Met314Ile-PHM (14).
FIGURE 5 Comparison (using cross-eyed stereo views) of the active sites of ox-Met314Ile-PHM (A and B) and ox-wt-PHM (C and D). Copper atoms and
water molecules are represented as pink and blue spheres, respectively. (A) Ox-Met314Ile-PHMwith the 2 Fo-Fc electron density map (blue), contoured at 0.9 s
and the anomalous diffraction difference Fourier map (pink), contoured at 4 s. (B) Ox-Met314Ile-PHMwith Fo-Fc difference Fourier map (green), contoured at
1.8 s and generated from a model that omitted all the atoms in A. (C) Ox-wt-PHM with the 2 Fo-Fc electron density map (blue), contoured at 1 s. (D) Ox-wt-
PHM with Fo-Fc difference Fourier map (green) contoured at 2.5 s and generated from a model that omitted all the atoms in C. This ﬁgure was prepared with
PyMOL (34).
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During this study, a new crystal form of the wt-PHM
was obtained. Despite differences in crystal contacts, the
structures of wt-PHM (in the oxidized and the reduced state)
in the new crystal form are essentially identical to those of
the equivalent structures in the previously reported crystal
form. These observations add further support to previous
studies arguing against mechanisms involving major con-
formational changes during the catalytic cycle of PHM.
Since PHM shares 32% sequence identity with dopamine-
b-monooxygenase (29) and has similar cofactor require-
ments (30) and kinetics (11), mechanistic insights obtained
with each enzyme have been used interchangeably (31).
Findings of the studies on PHM presented here are expected
to apply to dopamine-b-monooxygenase as well.
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